Federal Register / Vol. 90, No. 12 / Tuesday, January 21, 2025 / Notices 7173 

substance(s). Refer to SUPPLEMENTARY

INFORMATION listed below for further 

drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may submit 

electronic comments on or objections to 

the issuance of the proposed registration 

on or before March 24, 2025. Such 

persons may also file a written request 

for a hearing on the application on or 

before March 24, 2025. 

ADDRESSES: The Drug Enforcement 

Administration requires that all 

comments be submitted electronically 

through the Federal eRulemaking Portal, 

which provides the ability to type short 

comments directly into the comment 

field on the web page or attach a file for 

lengthier comments. Please go to 

https://www.regulations.gov and follow 

the online instructions at that site for 

submitting comments. Upon submission 

of your comment, you will receive a 

Comment Tracking Number. Please be 

aware that submitted comments are not 

instantaneously available for public 

view on https://www.regulations.gov. If 

you have received a Comment Tracking 

Number, your comment has been 

successfully submitted and there is no 

need to resubmit the same comment. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.33(a), this 

is notice that on September 27, 2024, 

Groff Health Inc., 2218 South Queen 

Street, York, Pennsylvania 17402–4631 

applied to be registered as a bulk 

manufacturer of the following basic 

class(es) of controlled substance(s): 

Controlled substance Drug 

code Schedule 

Psilocybin ....................... 7437 I 

Psilocyn .......................... 7438 I 

The company plans to bulk 

manufacture the listed controlled 

substances for internal use or for sale to 

its customers. No other activities for 

these drug codes are authorized for this 

registration. 

Matthew Strait, 

Deputy Assistant Administrator. 

[FR Doc. 2025–01349 Filed 1–17–25; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–1477] 

Bulk Manufacturer of Controlled 

Substances Application: Siegfried 

USA, LLC 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Siegfried USA, LLC has 

applied to be registered as a bulk 

manufacturer of basic class(es) of 

controlled substance(s). Refer to 

Supplementary Information listed below 

for further drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants, therefore, may submit 

electronic comments on or objections to 

the issuance of the proposed registration 

on or before March 24, 2025. Such 

persons may also file a written request 

for a hearing on the application on or 

before March 24, 2025. 

ADDRESSES: The Drug Enforcement 

Administration requires that all 

comments be submitted electronically 

through the Federal eRulemaking Portal, 

which provides the ability to type short 

comments directly into the comment 

field on the web page or attach a file for 

lengthier comments. Please go to 

https://www.regulations.gov and follow 

the online instructions at that site for 

submitting comments. Upon submission 

of your comment, you will receive a 

Comment Tracking Number. Please be 

aware that submitted comments are not 

instantaneously available for public 

view on https://www.regulations.gov. If 

you have received a Comment Tracking 

Number, your comment has been 

successfully submitted and there is no 

need to resubmit the same comment. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.33(a), this 

is notice that on November 20, 2024, 

Siegfried USA, LLC, 33 Industrial Park 

Road, Pennsville, New Jersey 08070– 

3244 applied to be registered as a bulk 

manufacturer of the following basic 

class(es) of controlled substance(s): 

Controlled substance Drug 

code Schedule 

Gamma Hydroxybutyric 

Acid.

2010 I 

Dihydromorphine ............ 9145 I 

Hydromorphinol .............. 9301 I 

Amphetamine ................. 1100 II 

Lisdexamfetamine .......... 1205 II 

Methylphenidate ............. 1724 II 

Amobarbital .................... 2125 II 

Pentobarbital .................. 2270 II 

Secobarbital .................... 2315 II 

Controlled substance Drug 

code Schedule 

Codeine .......................... 9050 II 

Oxycodone ..................... 9143 II 

Hydromorphone .............. 9150 II 

Hydrocodone .................. 9193 II 

Methadone ...................... 9250 II 

Methadone intermediate 9254 II 

Morphine ......................... 9300 II 

Oripavine ........................ 9330 II 

Thebaine ......................... 9333 II 

Opium tincture ................ 9630 II 

Oxymorphone ................. 9652 II 

Tapentadol ...................... 9780 II 

The company plans to bulk 

manufacture the listed controlled 

substances in bulk for sale to its 

customers. No other activities for these 

drug codes are authorized for this 

registration. 

Matthew Strait, 

Deputy Assistant Administrator. 

[FR Doc. 2025–01350 Filed 1–17–25; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–1474] 

Bulk Manufacturer of Controlled 

Substances Application: Invizyne 

Technologies, Inc. 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Invizyne Technologies, Inc. 

has applied to be registered as a bulk 

manufacturer of basic class(es) of 

controlled substance(s). Refer to 

Supplementary Information listed below 

for further drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants, therefore, may submit 

electronic comments on or objections to 

the issuance of the proposed registration 

on or before March 24, 2025. Such 

persons may also file a written request 

for a hearing on the application on or 

before March 24, 2025. 

ADDRESSES: The Drug Enforcement 

Administration requires that all 

comments be submitted electronically 

through the Federal eRulemaking Portal, 

which provides the ability to type short 

comments directly into the comment 

field on the web page or attach a file for 

lengthier comments. Please go to 

https://www.regulations.gov and follow 

the online instructions at that site for 

submitting comments. Upon submission 

of your comment, you will receive a 

Comment Tracking Number. Please be 


ddrumheller on DSK120RN23PROD with NOTICES1

I I 
7174 Federal Register / Vol. 90, No. 12 / Tuesday, January 21, 2025 / Notices 

aware that submitted comments are not 

instantaneously available for public 

view on https://www.regulations.gov. If 

you have received a Comment Tracking 

Number, your comment has been 

successfully submitted and there is no 

need to resubmit the same comment. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.33(a), this 

is notice that on November 14, 2024, 

Invizyne Technologies, Inc., 750 Royal 

Oaks Drive, Suite 106, Monrovia, 

California 91016–6357 applied to be 

registered as a bulk manufacturer of the 

following basic class(es) of controlled 

substance(s): 

Controlled substance Drug 

code Schedule 

Tetrahydrocannabinols ... 7370 I 

The company plans to bulk 

manufacture the listed controlled 

substance for the internal use 

intermediates or for sale to its 

customers. In reference to drug code 

7370 (Tetrahydrocannabinols), the 

company plans to bulk manufacture this 

drug as synthetic. No other activity for 

this drug code is authorized for this 

registration. 

Matthew Strait, 

Deputy Assistant Administrator. 

[FR Doc. 2025–01347 Filed 1–17–25; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

National Institute of Justice 

[OJP (NIJ) Docket No. 1833] 

Body Armor Manufacturer Workshop 

AGENCY: National Institute of Justice, 

Office of Justice Programs, U.S. 

Department of Justice. 

ACTION: Notice. 

SUMMARY: The National Institute of 

Justice (NIJ) will hold an online 

workshop for body armor manufacturers 

to provide updates on its standards and 

conformity assessment activities related 

to ballistic-resistant body armor. 

DATES: The workshop will be held 

online Wednesday, March 19, 2025, 

from 1 p.m. to 3 p.m. eastern time. 

FOR FURTHER INFORMATION CONTACT: 

Jared Gardner, Technology and 

Standards Advisor, Office of 

Technology and Standards, National 

Institute of Justice, 999 North Capitol 

Street NE, Washington, DC 20531, by 

telephone at (202) 702–2917 [Note: this 

is not a toll-free telephone number], or 

by email at jared.gardner@usdoj.gov. 

SUPPLEMENTARY INFORMATION: The 

National Institute of Justice (NIJ) will 

hold an online workshop for body armor 

manufacturers to provide updates on its 

standards and conformity assessment 

activities related to ballistic-resistant 

body armor. NIJ will discuss recent 

addenda to NIJ Standard 0101.07, 

‘‘Ballistic Resistance of Body Armor’’, 

and NIJ Standard 0123.00, 

‘‘Specification for NIJ Ballistic 

Protection Levels and Associated Test 

Threats’’. The NIJ Compliance Testing 

Program (CTP) will update program 

participants on the initial 

implementation of testing body armor to 

NIJ Standard 0101.07 (‘‘07’’) and the 

anticipated timeline for publication of 

the NIJ Compliant Products List (CPL) 

for those ‘‘07’’ armor models. The NIJ 

CTP will also discuss ongoing 

administration of the NIJ CPL for armor 

compliant with NIJ Standard 0101.06 

(‘‘06’’) and continued Follow-up 

Inspection and Testing (FIT) for those 

‘‘06’’ armor models. Potential revisions 

to NIJ CTP program requirements will 

also be discussed, including FIT testing 

procedures for ‘‘07’’ armor models listed 

on the NIJ CPL, disclosure of 

information about ballistic materials 

used to manufacture body armor 

submitted to the NIJ CTP for 

certification, and labeling requirements, 

among others. NIJ will also discuss 

potential changes to how information is 

displayed on the NIJ Compliant 

Products List and how it anticipates 

future updates to NIJ standards and NIJ 

CTP program requirements will be 

communicated. 

The workshop will be presented as an 

online webinar with opportunities for 

attendees to ask questions. To register 

for the workshop, please send an email 

to askctp@nijctp.org by 5 p.m. eastern 

time on Friday, March 14, 2025, and 

provide the name of your company and 

the names of the representatives who 

will attend. Please put ‘‘Body Armor 

Manufacturer Workshop’’ in the subject 

line of the email. A preliminary agenda 

will be sent to registered attendees 

approximately 48 hours prior to the 

workshop. 

For more information on NIJ’s 

standards and conformity assessment 

activities, please visit https://

nij.ojp.gov/topics/equipment-andtechnology/standards-and-conformityassessment. For more information on 

body armor, please visit https://

nij.ojp.gov/topics/equipment-andtechnology/body-armor. More 

information on the NIJ CTP can be 

found here: https://cjttec.org/ 

compliance-testing-program/. 

NIJ publishes this notice pursuant to 

its authority at 34 U.S.C. 10122(c) and 

6 U.S.C. 161–165. 

Nancy La Vigne, 

Director, National Institute of Justice. 

[FR Doc. 2025–01247 Filed 1–17–25; 8:45 am] 

BILLING CODE 4410–18–P 

DEPARTMENT OF LABOR 

Employee Benefits Security 

Administration 

[Exemption Application No. D–12101] 

Proposed Exemption From Certain 

Prohibited Transaction Restrictions 

Involving Northern Trust Corporation 

(Together With its Current and Future 

Affiliates, Northern or the Applicant) 

Located in Chicago, IL 

AGENCY: Employee Benefits Security 

Administration, Labor. 

ACTION: Notice of proposed exemption. 

SUMMARY: This document provides 

notice of the pendency before the 

Department of Labor (the Department) of 

a proposed individual exemption from 

certain prohibited transaction 

restrictions of the Employee Retirement 

Income Security Act of 1974 (ERISA) 

and the Internal Revenue Code of 1986 

(the Code). The proposed exemption 

would allow certain entities with 

specified relationships to Northern 

Trust Fiduciary Services (Guernsey) 

Limited (NTFS) (hereinafter, the 

Northern QPAMs, as further defined in 

section I(e) of the operative language) to 

rely on the exemptive relief provided by 

Prohibited Transaction Class Exemption 

84–14 (PTE 84–14 or the QPAM 

Exemption), notwithstanding the 

judgment of conviction (the Conviction) 

against NTFS for aiding and abetting tax 

fraud entered in France in the Paris 

Court of Appeal, French Special 

Prosecutor No. 1120392066, French 

Investigative Judge No. JIRSIF/11/12. 

DATES: 

Exemption date: This proposed 

exemption would be in effect for a 

period of five years beginning on March 

5, 2025, and ending on March 4, 2030 

(the Exemption Period). 

Comments due: Written comments 

and requests for a public hearing on the 

proposed exemption should be 

submitted to the Department by March 

7, 2025. 

ADDRESSES: All written comments and 

requests for a hearing should be 

submitted to the Employee Benefits 

Security Administration (EBSA), Office 

of Exemption Determinations, 

Attention: Application No. D–12101 via 


ddrumheller on DSK120RN23PROD with NOTICES1